Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.

Estimated impact on birth weight of scaling up intermittent preventive treatment of malaria in pregnancy given sulphadoxine-pyrimethamine resistance in Africa: A mathematical model

Open access
Walker, Patrick G. T., Floyd, Jessica, ter Kuile, Feiko, Cairns, Matt · 2017 · PLOS Medicine

Abstract

BACKGROUND: Malaria transmission has declined substantially in the 21st century, but pregnant women in areas of sustained transmission still require protection to prevent the adverse pregnancy and birth outcomes associated with malaria in pregnancy (MiP). A recent call to action has been issued to address the continuing low coverage of intermittent preventive treatment of malaria in pregnancy (IPTp). This call has, however, been questioned by some, in part due to concerns about resistance to sulphadoxine-pyrimethamine (SP), the only drug currently recommended for IPTp. METHODS AND FINDINGS: Using an existing mathematical model of MiP, we combined estimates of the changing endemicity of malaria across Africa with maps of SP resistance mutations and current coverage of antenatal access and IPTp with SP (IPTp-SP) across Africa. Using estimates of the relationship between SP resistance mutations and the parasitological efficacy of SP during pregnancy, we estimated the varying impact of IPTp-SP across Africa and the incremental value of enhancing IPTp-SP uptake to match current antenatal care (ANC) coverage. The risks of MiP and malaria-attributable low birthweight (mLBW) in unprotected pregnancies (i.e., those not using insecticide-treated nets [ITNs]) leading to live births fell by 37% (33%-41% 95% credible interval [crI]) and 31% (27%-34% 95% crI), respectively, from 2000 to 2015 across endemic areas in sub-Saharan Africa. However, these gains are fragile, and coverage is far from optimal. In 2015, 9.5 million (8.3 million-10.4 million 95% crI) of 30.6 million pregnancies in these areas would still have been infected with Plasmodium falciparum without intervention, leading to 750,000 (390,000-1.1 million 95% crI) mLBW deliveries. In all, 6.6 million (5.6 million-7.3 million 95% crI) of these 9.5 million (69.3%) pregnancies at risk of infection (and 53.4% [16.3 million/30.6 million] of all pregnancies) occurred in settings with near-perfect SP curative efficacy (>99%) based on the most recent estimates of resistance. Forty-four percent of these pregnancies (23% of all pregnancies) were not receiving any IPTp-SP despite making ≥3 ANC visits, representing 160,000 (94,000-236,000 95% crI) preventable low birthweight (LBW) deliveries. Only 4% (1.4 million) of pregnancies occurred in settings with >10% prevalence of the sextuple haplotype associated with compromised SP effectiveness. Forty-two percent of all pregnancies occurred in settings where the quintuple dhfr/dhps haplotype had become established but where in vivo efficacy data suggest SP maintains the majority of its effectiveness in clearing infections. Not accounting for protection from the use of ITNs during pregnancy, expanding IPTp-SP to all women with ≥3 ANC visits in Africa could prevent an additional 215,000 (128,000-318,000 95% crI) LBW deliveries. In 26 countries with sufficient recent data to estimate ITN impact (population-based ITN usage data that can be stratified by gravidity), we estimate that, due primarily to low ITN use by primigravidae, only 16.5% of the potential LBW births prevented by scaling up IPTp-SP would in fact have already have been prevented through ITN use. Our analysis also highlights the difficulties associated with estimating the relationship between the effectiveness of interventions against parasitological endpoints such as placental infection at delivery and health outcomes including birthweight, which is also determined by a wide range of unrelated factors. We also did not capture other aspects of malaria burden such as clinical malaria, maternal and neonatal anaemia, and miscarriage, all of which increase the overall importance of effective preventative strategies but have their own relationship with transmission intensity, parity, and SP resistance. CONCLUSIONS: Despite recent declines in malaria transmission in Africa, the burden of MiP in the absence of adequate prevention remains substantial. Even accounting for SP resistance, extending IPTp-SP to all women attending ANC, as well as long-lasting insecticidal net distribution targeted towards first-time mothers, would have a sizeable impact upon maternal and infant health in almost all malaria-endemic settings in sub-Saharan Africa.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pmed.1002243

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig 1 Preventable malaria burden and sulphadoxine-pyrimethamine resistance. (A) Percent of pregnancies infected in the absence of intervention in 2015. (B) Percent of pregnancies leading to malaria-attributable LBW in 2015 in the absence of intervention. (C) Prevalence of the quintuple K540E mutation within infected individuals. (D) Prevalence of the sextuple A581G mutation within infected individuals. (E) Percent of pregnancies leading to malaria-attributable LBW due to infection involving the quintuple mutation. (F) Percent of pregnancies leading to malaria-attributable LBW due to infection involving the sextuple mutation. LBW, low birthweight.
Fig 1 Preventable malaria burden and sulphadoxine-pyrimethamine resistance. (A) Percent of pregnancies infected in the absence of intervention in 2015. (B) Percent of pregnancies leading to malaria-attributable LBW in 2015 in the absence of intervention. (C) Prevalence of the quintuple K540E mutation within infected individuals. (D) Prevalence of the sextuple A581G mutation within infected individuals. (E) Percent of pregnancies leading to malaria-attributable LBW due to infection involving the quintuple mutation. (F) Percent of pregnancies leading to malaria-attributable LBW due to infection involving the sextuple mutation. LBW, low birthweight.CC BY · PubMed Central
Fig 2 Impact of IPTp-SP upon low birthweight and effect of resistance. (A) Comparison between modelled (lines) and observed (circles with bars indicating 95% confidence intervals) 28- and 42-d failure rates in different resistance settings. Solid lines show a setting where the original prevalence at first ANC visit was 45% (replicating the high transmission settings in which these data were collected) [22]. The dashed green line shows a model simulation from a setting with 20% prevalence at first ANC visit (to reflect the relatively lower prevalence setting of Mansa, Zambia [22]). Prophylaxis in the model is assumed to last for an average duration of 28 d (low quintuple mutation), 14 d (intermediate quintuple mutation), and 7 d (high quintuple mutation). Recrudescent infections (estimated by the PCR-corrected failure rate, not shown) were assumed to reappear uniformly throughout the observation period. (B) Example simulations of placental prevalence by week of gestation in the absence of intervention, and where sulphadoxine-pyrimethamine is given at 17, 25, and 32 wk gestation at the different levels of resistance. (C) How efficacy of IPTp-SP against LBW is assumed to vary by resistance category and transmission intensity (based on changes in the estimated average time spent infected). ANC, antenatal care; IPTp-SP, intermittent preventive treatment of malaria in pregnancy with sulphadoxine-pyrimethamine; LBW, low birthweight.
Fig 2 Impact of IPTp-SP upon low birthweight and effect of resistance. (A) Comparison between modelled (lines) and observed (circles with bars indicating 95% confidence intervals) 28- and 42-d failure rates in different resistance settings. Solid lines show a setting where the original prevalence at first ANC visit was 45% (replicating the high transmission settings in which these data were collected) [22]. The dashed green line shows a model simulation from a setting with 20% prevalence at first ANC visit (to reflect the relatively lower prevalence setting of Mansa, Zambia [22]). Prophylaxis in the model is assumed to last for an average duration of 28 d (low quintuple mutation), 14 d (intermediate quintuple mutation), and 7 d (high quintuple mutation). Recrudescent infections (estimated by the PCR-corrected failure rate, not shown) were assumed to reappear uniformly throughout the observation period. (B) Example simulations of placental prevalence by week of gestation in the absence of intervention, and where sulphadoxine-pyrimethamine is given at 17, 25, and 32 wk gestation at the different levels of resistance. (C) How efficacy of IPTp-SP against LBW is assumed to vary by resistance category and transmission intensity (based on changes in the estimated average time spent infected). ANC, antenatal care; IPTp-SP, intermittent preventive treatment of malaria in pregnancy with sulphadoxine-pyrimethamine; LBW, low birthweight.CC BY · PubMed Central
Fig 3 The current coverage of IPTp-SP and potential impact of scale-up. (A) Current coverage of IPTp (at least two doses of SP received at some stage during pregnancy) by first administrative unit according to the most recent population-based survey. (B) Current coverage of women visiting an ANC clinic at least three times during pregnancy. (C) Estimate of the current impact of IPTp-SP given current coverage, SP resistance, and transmission intensity (purple areas show settings where the sextuple mutation has become established, where we do not make an estimate of efficacy). (D) Estimate of the impact of IPTp-SP if given to all women visiting an ANC clinic at least three times, with purple areas as in (C). (E) Estimates of the total number of pregnancies receiving IPTp, and the ANC status of those who do not, by resistance category. (F) Equivalent estimates of total infected pregnancies. (G) Equivalent estimates of potential malaria-attributable LBW deliveries. ANC, antenatal care; IPTp, intermittent preventive treatment of malaria in pregnancy; IPTp-SP, intermittent preventive treatment of malaria in pregnancy with sulphadoxine-pyrimethamine; LBW, low birthweight; SP, sulphadoxine-pyrimethamine.
Fig 3 The current coverage of IPTp-SP and potential impact of scale-up. (A) Current coverage of IPTp (at least two doses of SP received at some stage during pregnancy) by first administrative unit according to the most recent population-based survey. (B) Current coverage of women visiting an ANC clinic at least three times during pregnancy. (C) Estimate of the current impact of IPTp-SP given current coverage, SP resistance, and transmission intensity (purple areas show settings where the sextuple mutation has become established, where we do not make an estimate of efficacy). (D) Estimate of the impact of IPTp-SP if given to all women visiting an ANC clinic at least three times, with purple areas as in (C). (E) Estimates of the total number of pregnancies receiving IPTp, and the ANC status of those who do not, by resistance category. (F) Equivalent estimates of total infected pregnancies. (G) Equivalent estimates of potential malaria-attributable LBW deliveries. ANC, antenatal care; IPTp, intermittent preventive treatment of malaria in pregnancy; IPTp-SP, intermittent preventive treatment of malaria in pregnancy with sulphadoxine-pyrimethamine; LBW, low birthweight; SP, sulphadoxine-pyrimethamine.CC BY · PubMed Central
Fig 4 Usage of insecticide-treated nets in pregnancy. ITN usage prior to pregnancy (A) and during pregnancy (B) by parity (based on use during night preceding interview and weighted by age to reflect fertility patterns). Grey lines show usage estimates from each of the 26 country-level surveys with sufficient data, black lines show the median estimate of usage across surveys, and red lines show the estimate weighted by country population size, incorporating pixel-level urban and rural patterns. (C) Estimate of ITN usage weighted by population size within all pregnancies, within potentially infected pregnancies, and within pregnancies potentially leading to LBW. ITN, insecticide-treated net; LBW, low birthweight.
Fig 4 Usage of insecticide-treated nets in pregnancy. ITN usage prior to pregnancy (A) and during pregnancy (B) by parity (based on use during night preceding interview and weighted by age to reflect fertility patterns). Grey lines show usage estimates from each of the 26 country-level surveys with sufficient data, black lines show the median estimate of usage across surveys, and red lines show the estimate weighted by country population size, incorporating pixel-level urban and rural patterns. (C) Estimate of ITN usage weighted by population size within all pregnancies, within potentially infected pregnancies, and within pregnancies potentially leading to LBW. ITN, insecticide-treated net; LBW, low birthweight.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 42 references

Research works printed but not linked: 2

  1. Njagi JK. The effects of sulfadoxine-pyrimethamine intermittent treatment and pyrethroid impregnated bed nets on malaria morbidity and birth weight in Bondo district, Kenya [dissertation]. Nairobi: University of Nairobi; 2002.
  2. PGT Walker, 2014, Estimated risk of placental infection and low birthweight attributable to Plasmodium falciparum malaria in Africa in 2010: a modelling study, Lancet Glob Heal, 2, e460, 10.1016/S2214-109X(14)70256-6 · DOI

Cited by

See all 73

Metadata

Authors
Walker, P. G. T., Floyd, J., ter Kuile, F., & Cairns, M.
Affiliations
Imperial College London (GB)
Corresponding author
Walker, Patrick G. T.
Venue
PLOS Medicine
Published
2017-02-28
Volume
14
Issue
2
Pages
e1002243
ISSN
  • 1549-1277 (ISSN-L)
  • 1549-1676
OpenAlex
W2593801067
Cited by
73
References
42
Citations by year
2026: 3 · 2025: 4 · 2024: 5 · 2023: 10 · 2022: 12 · 2021: 8 · 2020: 7 · 2019: 8 · 2018: 7 · 2017: 9
FWCI
7.96
Type
journal article
Language
en
Open access
Locations
  • PLoS Medicine (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • LSTM Online Archive (Liverpool School of Tropical Medicine) (acceptedVersion)
  • LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Figshare (submittedVersion, cc-by)
  • Spiral (Imperial College London) (submittedVersion, cc-by)
  • Greater South Information System
Funders
  • Medical Research Council
  • Department for International Development
  • European and Developing Countries Clinical Trials Partnership
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Global Maternal and Child Health
  • Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
Keywords
malaria in pregnancy, intermittent preventive treatment in pregnancy, sulfadoxine-pyrimethamine resistance, Plasmodium falciparum, low birth weight, antenatal care coverage, IPTp uptake, malaria endemicity, insecticide-treated nets, sub-Saharan Africa
MeSH terms
Antimalarials, Birth Weight, Child, Child, Preschool, Drug Combinations, Female, Humans, Malaria, Models, Theoretical, Pregnancy, Pyrimethamine, Sulfadoxine, Africa South of the Sahara, Drug Resistance, Multiple

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Estimated impact on birth weight of scaling up intermittent preventive treatment of malaria in pregnancy given sulphadoxine-pyrimethamine resistance in Africa: A mathematical model. https://app.cochat.ai/papers/10.1371/journal.pmed.1002243
The paper
Walker, P. G. T., Floyd, J., ter Kuile, F., & Cairns, M. (2017). Estimated impact on birth weight of scaling up intermittent preventive treatment of malaria in pregnancy given sulphadoxine-pyrimethamine resistance in Africa: A mathematical model. PLOS Medicine. https://doi.org/10.1371/journal.pmed.1002243

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.